Strategies targeting the IL-4/IL-13 axes in disease.

Related Articles

Strategies targeting the IL-4/IL-13 axes in disease.

Cytokine. 2015 Aug 5;

Authors: May RD, Fung M

Abstract
IL-4 and IL-13 are pleiotropic Th2 cytokines produced by a wide variety of different cell types and responsible for a broad range of biology and functions. Physiologically, Th2 cytokines are known to mediate host defense against parasites but they can also trigger disease if their activities are dysregulated. In this review we discuss the rationale for targeting the IL-4/IL-13 axes in asthma, atopic dermatitis, allergic rhinitis, COPD, cancer, inflammatory bowel disease, autoimmune disease and fibrotic disease as well as evaluating the associated clinical data derived from blocking IL-4, IL-13 or IL-4 and IL-13 together.

PMID: 26255210 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Targeting CCL28 Protein Structure May Help Prevent Asthma, Study Shows – Lung Disease News


Lung Disease News

Targeting CCL28 Protein Structure May Help Prevent Asthma, Study Shows
Lung Disease News
Asthma is a chronic inflammatory disease of the air passages characterized by airflow obstruction and with common symptoms of wheezing, coughing and shortness of breath. Currently, there is no cure for asthma and affects approximately 25 million people

View full post on asthma – Google News

Scientists report new approach to defeating asthma by targeting allergen – News-Medical.net

Scientists report new approach to defeating asthma by targeting allergen
News-Medical.net
Current asthma treatments can alleviate wheezing, coughing and other symptoms felt by millions of Americans every year, but they don't get to the root cause of the condition. Now, for the first time, scientists are reporting a new approach to defeating

and more »

View full post on asthma – Google News